Insider · CIK 0001881403

Benecchi Christopher

Reports to the SEC for 1 company · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001881403

Forms 4 and 5

Insider transactions

23 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-07-31	Sage Therapeutics, Inc.D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−28.1K sh	—	—	0
2025-07-31	Sage Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−40K sh	—	—	0
2025-07-31	Sage Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−12.5K sh	—	—	0
2025-07-31	Sage Therapeutics, Inc.D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−36.4K sh	—	—	0
2025-04-10	Sage Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+2,712 sh	—	—	49,089
2025-04-10	Sage Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−661 sh	$6.91	−$4,567.51	48,428
2025-04-10	Sage Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+3,255 sh	—	—	47,170
2025-04-10	Sage Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−793 sh	$6.91	−$5,479.63	46,377
2025-02-13	Sage Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−822 sh	$7.18	−$5,901.96	43,915
2025-01-16	Sage Therapeutics, Inc.Stock Options (Right to buy)A Award	Chief Operating Officer	AAward	+40K sh	—	—	40,000
2025-01-16	Sage Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+20K sh	—	—	44,737
2024-11-01	Sage Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+6,250 sh	—	—	24,737
2024-11-01	Sage Therapeutics, Inc.Stock Option (Right to buy)A Award	Chief Operating Officer	AAward	+12.5K sh	—	—	12,500
2024-08-05	Sage Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+16.2K sh	—	—	23,242
2024-08-05	Sage Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−4,755 sh	$8.96	−$42.6K	18,487
2024-02-13	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+27K sh	—	—	27,000
2024-02-13	Sage Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+13.5K sh	—	—	19,430
2023-02-13	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+20.9K sh	—	—	20,900
2023-02-03	Sage Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+6,750 sh	—	—	7,379
2023-02-03	Sage Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−2,119 sh	$44.16	−$93.6K	5,260
2022-06-16	Sage Therapeutics, Inc.Stock Options (Right to buy)A Award	Chief Operating Officer	AAward	+9,500 sh	—	—	9,500
2022-02-11	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+11.4K sh	—	—	11,400
2021-10-01	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+45K sh	—	—	45,000

Recent filings

Accepted (ET)
Jul 314
Benecchi Christopher0000950170-25-100689
SEC(opens sec.gov)
Apr 114
Benecchi Christopher0001562180-25-003114
SEC(opens sec.gov)
Feb 144
Benecchi Christopher0001562180-25-001202
SEC(opens sec.gov)
Jan 214
Benecchi Christopher0001562180-25-000435
SEC(opens sec.gov)
Nov 144
Benecchi Christopher0001562180-24-007692
SEC(opens sec.gov)
Aug 74
Benecchi Christopher0001562180-24-006086
SEC(opens sec.gov)
Feb 154
Benecchi Christopher0001562180-24-001334
SEC(opens sec.gov)
Feb 154
Benecchi Christopher0001562180-23-001424
SEC(opens sec.gov)
Feb 74
Benecchi Christopher0001562180-23-001079
SEC(opens sec.gov)

Companies

Sage Therapeutics, Inc.Chief Operating Officer

Address

C/O SAGE THERAPEUTICS, INC. 55 CAMBRIDGE PARKWAY

CAMBRIDGE, MA, 02142